Latest from Christopher Rowland

FDA has decided at least 60 million doses of Johnson & Johnson’s coronavirus vaccine must be discarded; 10 million can be released

The doses underwent a safety review after J&J shots were contaminated with AstraZeneca’s vaccine, prompting a plant shutdown.
  • Jun 11, 2021

Johnson & Johnson documented contamination risks at Baltimore plant months before vaccine was ruined

The House Oversight select subcommittee on the coronavirus crisis is investigating events at Emergent BioSolutions that led to a vaccine production shutdown that is now in its fifth week.
  • May 19, 2021

Johnson & Johnson vaccine shipments to states dwindle to zero as production freeze continues

Allocations to states of Johnson & Johnson's one-shot vaccine dry up after contamination crisis at Baltimore subcontractor Emergent BioSolutions
  • May 13, 2021

Pfizer coronavirus vaccine revenue is projected to hit $26 billion in 2021 with production surge

Pfizer has jumped ahead in the race to produce billions of doses of vaccine per year and plans to expand its use of mRNA technology into new vaccines and therapies.
  • May 4, 2021

Johnson & Johnson suffers another setback as FDA tells Md. vaccine maker to suspend production

The pause in production follows the contamination of 15 million doses of Johnson & Johnson vaccine in March.
  • Apr 19, 2021

Rare side effects cast cloud over vaccines much of the world desperately needs

Pfizer and Moderna shots, based on mRNA technology, mostly have served wealthy nations. AstraZeneca and Johnson & Johnson vaccines are expected to fill the global gap.
  • Apr 14, 2021

FDA, CDC call for pause in use of Johnson & Johnson vaccine after ‘extremely rare’ cases of blood clots

The agencies said Tuesday that they are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the shot.
  • Apr 13, 2021

CEO at troubled vaccine plant received 51 percent compensation boost in 2020

Emergent Chief Executive Robert Kramer received $5.6 million in 2020 in salary, bonus, stocks, and stock option awards, according to a company filing Friday. Manufacturing problems at the plant this year ruined 15 million doses of Johnson & Johnson coronavirus vaccine.
  • Apr 10, 2021